Altesa

About:

Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments

Description:

Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments against age-old threats to human health: high-consequence viral pathogens.

Total Funding Amount:

$35M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

College Park, Georgia, United States

Founded Date:

2022-01-01

Contact Email:

inquiries(AT)AltesaBio.com

Founders:

George Painter, Seth Rudnick

Number of Employees:

1-10

Last Funding Date:

2023-01-04

IPO Status:

Private

Industries: